NCT07816445 · Arizona State University
Pilot Study of an Interparental Conflict Intervention for Separating or Divorcing Parents
What this study is about
This pilot study will evaluate a new intervention for parents who are separated or divorced and have been court ordered to participate in a program addressing interparental conflict. The intervention is designed to teach parents skills to reduce children's exposure to conflict between parents and support children's well-being.
View original scientific description
This pilot study will evaluate a new intervention for parents who are separated or divorced and have been court ordered to participate in a program addressing interparental conflict. The intervention is designed to teach parents skills to reduce children's exposure to conflict between parents and support children's well-being. Participants will be randomly assigned to either the new intervention or an existing court-based program. The study will examine the feasibility, acceptability, appropriateness, and usability of the new intervention and its effects on interparental conflict, parents' use of protective skills, and children's mental health.
Interventions
BEHAVIORAL
Family COMPASS
Family COMPASS (Conflict Management through Purposeful Awareness, Strategies, and Support) is a manualized, trauma-informed parenting intervention designed to reduce children's exposure to interparental conflict following parental separation or divorce. The intervention consists of four highly structured, approximately 30-minute sessions delivered virtually or in person by trained personnel. It focuses on strengthening parents' emotion regulation, communication, co-parenting, conflict management, and safety planning skills.
BEHAVIORAL
Families in Transition (FIT)
FIT is a 90-minute online parent education program developed by the Superior Court of Maricopa County in collaboration with the National Center for State Courts. The program includes four modules, a film, and interactive activities. It validates parents' difficult feelings toward their co-parent while emphasizing behavior change to protect children from interparental conflict. Content addresses the effects of interparental conflict on children, prioritizing children's needs, developing a child-focused vision for the future, and using practical strategies to reduce conflict behaviors.
Primary outcome measures
Child Anxiety Symptoms
Time frame: Baseline and 30 days after program completion
Parent-reported child anxiety symptoms assessed using the Anxiety subscale of the Revised Child Anxiety and Depression Scale-25 Parent Version (RCADS-25-P). The Anxiety subscale contains 15 items rated from 0 (Never) to 3 (Always). Raw scores range from 0 to 45, with higher scores indicating greater anxiety symptoms.
Child Depressive Symptoms
Time frame: Baseline and 30 days after program completion
Parent-reported child depressive symptoms assessed using the Depression subscale of the Revised Child Anxiety and Depression Scale-25 Parent Version (RCADS-25-P). The Depression subscale contains 10 items rated from 0 (Never) to 3 (Always). Raw scores range from 0 to 30, with higher scores indicating greater depressive symptoms.
Child Irritability/Anger
Time frame: Baseline and 30 days after program completion
Parent-reported child irritability and anger assessed using the irritability/anger item of the DSM-5 Level 1 Cross-Cutting Symptom Measure-Parent/Guardian-Rated Measure for Children Ages 6-17. The item is rated from 0 (Not at all) to 4 (Nearly every day). Scores range from 0 to 4, with higher scores indicating greater irritability/anger.
Child Attention Problems
Time frame: Baseline and 30 days after program completion
Parent-reported child attention problems assessed using the attention item of the DSM-5 Level 1 Cross-Cutting Symptom Measure-Parent/Guardian-Rated Measure for Children Ages 6-17. The item is rated from 0 (Not at all) to 4 (Nearly every day). Scores range from 0 to 4, with higher scores indicating greater attention problems.
Interparental Conflict
Time frame: Baseline and 30 days after program completion
Parent-reported interparental conflict assessed using the 13-item intensity and frequency subscales of the Children's Perception of Interparental Conflict Scale, adapted for parent report. Items are rated on a 3-point scale and appropriately reverse-scored. Using summed item scores coded from 0 to 2, total scores range from 0 to 26, with higher scores indicating greater interparental conflict.
Intervention Feasibility
Time frame: Approximately 30 days after program completion
Parent-reported feasibility assessed using the 4-item Feasibility of Intervention Measure (FIM). Items are rated from 1 (Completely disagree) to 5 (Completely agree), with scores ranging from 4 to 20. Higher scores indicate greater perceived feasibility.
Intervention Acceptability
Time frame: Approximately 30 days after program completion
Parent-reported acceptability assessed using the 4-item Acceptability of Intervention Measure (AIM). Items are rated from 1 (Completely disagree) to 5 (Completely agree), with scores ranging from 4 to 20. Higher scores indicate greater acceptability.
Intervention Appropriateness
Time frame: Approximately 30 days after program completion
Parent-reported appropriateness assessed using the 4-item Intervention Appropriateness Measure (IAM). Items are rated from 1 (Completely disagree) to 5 (Completely agree), with scores ranging from 4 to 20. Higher scores indicate greater perceived appropriateness.
Intervention Usability
Time frame: Approximately 30 days after program completion
Parent-reported intervention usability assessed using the 10-item Intervention Usability Scale (IUS). Items are rated on a 5-point agreement scale. Positively and negatively worded items are scored according to standard IUS scoring procedures, and the summed score is multiplied by 2.5. Total scores range from 0 to 100, with higher scores indicating greater perceived intervention usability.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Age 18 years or older
- Fluent in English
- Court ordered to attend an intervention to reduce interparental conflict
Where
- Tempe, Arizona
Collaborators
National Institute of Mental Health (NIMH)
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Sep 11, 2026 · Source of record for eligibility and locations